Quarterly report pursuant to sections 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS EQUITY DEFICIENCY

v2.3.0.11
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS EQUITY DEFICIENCY (USD $)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance at Dec. 31, 2011 $ 114,274 $ 66,069,911 $ (69,289,467) $ (3,105,282)
Balance (in Shares) at Dec. 31, 2011 114,273,470      
Common stock issued for convertible debt 9,703 2,416,008   2,425,711
Common stock issued for convertible debt (in Shares) 9,702,844      
Common stock issued upon exercise of warrants 867 346,033   346,900
Common stock issued upon exercise of warrants (in Shares) 867,250      
Fair value of options and warrants issued as compensation   564,992   564,992
Common stock issued upon exercise of options 18 4,932   4,950
Common stock issued upon exercise of options (in Shares) 18,334      
Common stock issued for services 500 149,500   150,000
Common stock issued for services (in Shares) 500,000      
Fair value of warrants issued to consultants   238,276   238,276
Fair value of warrants and beneficial conversion feature of issued convertible notes   1,354,980   1,354,980
Net loss for the three months ended March 31, 2012     (5,470,350) (5,470,350)
Balance at Mar. 31, 2012 $ 125,362 $ 71,144,632 $ (74,759,817) $ (3,489,823)
Balance (in Shares) at Mar. 31, 2012 125,361,898